Advertisement
U.S. markets open in 3 hours 28 minutes
  • S&P Futures

    5,204.50
    -10.25 (-0.20%)
     
  • Dow Futures

    39,167.00
    -56.00 (-0.14%)
     
  • Nasdaq Futures

    18,186.50
    -45.00 (-0.25%)
     
  • Russell 2000 Futures

    2,042.80
    -7.00 (-0.34%)
     
  • Crude Oil

    82.62
    -0.10 (-0.12%)
     
  • Gold

    2,156.50
    -7.80 (-0.36%)
     
  • Silver

    25.09
    -0.17 (-0.67%)
     
  • EUR/USD

    1.0844
    -0.0033 (-0.30%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.62
    +0.29 (+2.02%)
     
  • GBP/USD

    1.2673
    -0.0055 (-0.43%)
     
  • USD/JPY

    150.6600
    +1.5620 (+1.05%)
     
  • Bitcoin USD

    64,027.01
    -3,840.34 (-5.66%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,719.41
    -3.14 (-0.04%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

William Blair Cautious On North American P&C Insurance Market, Moves To Sidelines On Sapiens International

Sapiens International Corporation N.V. (NASDAQ: SPNS), an Israeli software solutions provider for the insurance industry, reported Monday before the market open with first-quarter results that showed non-GAAP earnings per share of 13 cents, ahead of the 10-cent consensus. Revenue of $71 million also exceeded expectations. The company maintained its full-year guidance.

The Analyst

William Blair analyst Justin Furby downgraded Sapiens from Outperform to Market Perform.

The Thesis

Sapiens' Q1 print and commentary on the the pipeline for recently acquired Adaptik were encouraging, but near-to-medium concerns exist on whether Sapiens can boost organic growth in its North American property and casualty business, Furby said in a Tuesday note.

With the company's life insurance business on a slight decline and pipelines remaining soft, the North American P&C business is key to Sapiens' growth, the analyst said.

"We are taking a more cautious approach and waiting for additional proof points that management's strategy within the North American P&C market is working."

The Street estimates for Sapiens in 2019 could be "a bit too aggressive," Furby said.

William Blair attributed the top-line Q1 beat to better-than-expected top-line integration of the Adaptik acquisition, which was completed March 5, and earlier-than-expected revenue from some DECISION deals.

Sapiens shares trade at 16.6 times William Blair's calendar 2019 EPS estimates, at a discount to the comp group's 19.7 times multiple.

The Price Action

Sapiens shares have lost about 15.8 percent year-to-date.

The stock was down 3.3 percent at the time of publication at $9.38.

Related Links:

Zuora's Growth, Profitability Are Priced In, Morgan Stanley Says In Neutral Initiation

Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential

Latest Ratings for SPNS

May 2018

William Blair

Downgrades

Outperform

Market Perform

Feb 2018

Barclays

Downgrades

Overweight

Equal-Weight

Sep 2017

Cowen & Co.

Initiates Coverage On

Outperform

View More Analyst Ratings for SPNS
View the Latest Analyst Ratings

See more from Benzinga

© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement